Insider · CIK 0001361580

Basgoz Nesli

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001361580

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-05-08	Allergan plcD Disposition to Issuer	Director	DDisposition to Issuer	−6,888.913 sh	—	—	0
2020-05-08	Allergan plcStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−2,619 sh	—	—	0
2020-05-08	Allergan plcStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−3,691 sh	—	—	0
2020-05-08	Allergan plcStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−2,790 sh	—	—	0
2020-05-01	Allergan plcF Tax Payment	Director	FTax Payment	−991 sh	$189.74	−$188K	6,888.913
2020-04-13	Allergan plcG Gift	Director	GGift	−280 sh	—	—	7,879.913
2019-12-06	Allergan plcG Gift	Director	GGift	−47 sh	—	—	8,159.913
2019-05-02	Allergan plcA Award	Director	AAward	+2,064 sh	$145.33	+$300K	8,206.913
2019-04-30	Allergan plcF Tax Payment	Director	FTax Payment	−953 sh	$147.00	−$140K	6,142.913
2018-09-04	Allergan plcG Gift	Director	GGift	−263 sh	—	—	7,095.913
2018-08-30	Allergan plcS Sale	Director	SSale	−1,055 sh	$190.05	−$201K	7,358.913
2018-08-10	Allergan plcF Tax Payment	Director	FTax Payment	−834 sh	$184.00	−$153K	8,413.913
2018-08-10	Allergan plcM Exercise/Conversion	Director	MExercise/Conversion	+1,889 sh	$81.16	+$153K	9,247.913
2018-08-10	Allergan plcNon-Qualified Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,889 sh	—	—	0
2018-05-02	Allergan plcA Award	Director	AAward	+1,985 sh	$151.07	+$300K	7,358.913
2018-05-01	Allergan plcF Tax Payment	Director	FTax Payment	−588 sh	$152.94	−$89.9K	5,373.913
2017-12-08	Allergan plcG Gift	Director	GGift	−15 sh	—	—	5,982.913
2017-12-08	Allergan plcG Gift	Director	GGift	−15 sh	—	—	5,961.913
2017-12-08	Allergan plcG Gift	Director	GGift	−6 sh	—	—	5,976.913
2017-12-08	Allergan plcG Gift	Director	GGift	−45 sh	—	—	5,997.913
2017-06-16	Allergan plcL Small Acquisition	Director	LSmall Acquisition	+6.55 sh	$235.96	+$1,545.538	6,042.913
2017-05-18	Allergan plcM Exercise/Conversion	Director	MExercise/Conversion	+1,889 sh	$84.44	+$160K	7,919
2017-05-18	Allergan plcS Sale	Director	SSale	−1,889 sh	$220.45	−$416K	6,030
2017-05-18	Allergan plcNon-Qualified Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,889 sh	—	—	0
2017-05-04	Allergan plcA Award	Director	AAward	+1,223 sh	$245.25	+$300K	6,030
2017-05-03	Allergan plcF Tax Payment	Director	FTax Payment	−668 sh	$243.76	−$163K	4,807
2017-03-29	Allergan plcL Small Acquisition	Director	LSmall Acquisition	+6.363 sh	$242.21	+$1,541.182	5,481.363
2016-12-22	Allergan plcG Gift	Director	GGift	−40 sh	—	—	5,475
2016-12-08	Allergan plcS Sale	Director	SSale	−500 sh	$188.72	−$94.4K	5,515
2016-08-15	Allergan plcF Tax Payment	Director	FTax Payment	−100 sh	$254.05	−$25.4K	6,015
2016-08-08	Allergan plcA Award	Director	AAward	+201 sh	$248.31	+$49.9K	6,115
2016-08-05	Allergan plcM Exercise/Conversion	Director	MExercise/Conversion	+1,889 sh	$97.62	+$184K	6,672
2016-08-05	Allergan plcS Sale	Director	SSale	−758 sh	$253.02	−$192K	5,914
2016-08-05	Allergan plcEmployee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+1,889 sh	—	—	12,878
2016-05-11	Allergan plcM Exercise/Conversion	Director	MExercise/Conversion	+459 sh	$82.53	+$37.9K	5,242
2016-05-11	Allergan plcS Sale	Director	SSale	−459 sh	$225.10	−$103K	4,783
2016-05-11	Allergan plcEmployee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−459 sh	—	—	459
2016-05-05	Allergan plcA Award	Director	AAward	+1,188 sh	$210.34	+$250K	4,783
2016-05-04	Allergan plcF Tax Payment	Director	FTax Payment	−397 sh	$214.62	−$85.2K	3,595
2015-12-15	Allergan plcG Gift	Director	GGift	−62 sh	—	—	3,992
2015-12-11	Allergan plcG Gift	Director	GGift	−8 sh	—	—	4,054
2015-12-07	Allergan plcS Sale	Director	SSale	−2,300 sh	$312.96	−$720K	4,062
2015-12-07	Allergan plcEmployee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,300 sh	—	—	459
2015-12-07	Allergan plcM Exercise/Conversion	Director	MExercise/Conversion	+2,300 sh	$82.53	+$190K	6,362
2015-08-23	Allergan plcF Tax Payment	Director	FTax Payment	−124 sh	$298.57	−$37K	4,062
2015-08-15	Allergan plcF Tax Payment	Director	FTax Payment	−100 sh	$314.50	−$31.5K	4,186
2015-06-09	Allergan plcS Sale	Director	SSale	−2,200 sh	$297.89	−$655K	4,286
2015-06-09	Allergan plcM Exercise/Conversion	Director	MExercise/Conversion	+2,200 sh	$82.53	+$182K	6,486
2015-06-09	Allergan plcStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,200 sh	—	—	2,759
2015-06-05	Allergan plcA Award	Director	AAward	+826 sh	$302.30	+$250K	4,286

Recent filings

Accepted (ET)
May 124
Basgoz Nesli0000899243-20-012768
SEC(opens sec.gov)
May 44
Basgoz Nesli0001179110-20-005452
SEC(opens sec.gov)
Dec 94
Basgoz Nesli0001179110-19-012537
SEC(opens sec.gov)
May 24
Basgoz Nesli0001179110-19-005396
SEC(opens sec.gov)
Sep 44
Basgoz Nesli0001179110-18-011086
SEC(opens sec.gov)
Aug 144
Basgoz Nesli0001179110-18-010585
SEC(opens sec.gov)
May 44
Basgoz Nesli0001179110-18-006347
SEC(opens sec.gov)
May 34
Basgoz Nesli0001179110-18-006109
SEC(opens sec.gov)
Dec 264
Basgoz Nesli0001179110-17-015860
SEC(opens sec.gov)

Companies

Address

C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE

NEW YORK, NY, 10022